Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C29H35NO4 |
| Molecular Weight | 461.5925 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC1=CC=C(C=C1)[C@H]2C[C@@]3(C)[C@@H](CC[C@]3(OC(C)=O)C(C)=O)[C@@H]4CCC5=CC(=O)CCC5=C24
InChI
InChIKey=AQCANMLYXHZIRW-GCNJZUOMSA-N
InChI=1S/C29H35NO4/c1-17(31)29(34-18(2)32)14-13-26-24-11-7-20-15-22(33)10-12-23(20)27(24)25(16-28(26,29)3)19-5-8-21(30-4)9-6-19/h5-6,8-9,15,24-26,30H,7,10-14,16H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1
| Molecular Formula | C29H35NO4 |
| Molecular Weight | 461.5925 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 00:43:13 GMT 2025
by
admin
on
Wed Apr 02 00:43:13 GMT 2025
|
| Record UNII |
5LN8BT223W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
159681-66-0
Created by
admin on Wed Apr 02 00:43:13 GMT 2025 , Edited by admin on Wed Apr 02 00:43:13 GMT 2025
|
PRIMARY | |||
|
15908064
Created by
admin on Wed Apr 02 00:43:13 GMT 2025 , Edited by admin on Wed Apr 02 00:43:13 GMT 2025
|
PRIMARY | |||
|
5LN8BT223W
Created by
admin on Wed Apr 02 00:43:13 GMT 2025 , Edited by admin on Wed Apr 02 00:43:13 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
BINDING
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Biological Half-life | PHARMACOKINETIC |
|
micronized tablet |
|
||
| Tmax | PHARMACOKINETIC |
|
single dose administration of ulipristal acetate |
|
||